Correlation Between Ningbo MedicalSystem and Hangzhou Prevail

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Hangzhou Prevail at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Hangzhou Prevail into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Hangzhou Prevail Optoelectronic, you can compare the effects of market volatilities on Ningbo MedicalSystem and Hangzhou Prevail and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Hangzhou Prevail. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Hangzhou Prevail.

Diversification Opportunities for Ningbo MedicalSystem and Hangzhou Prevail

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Ningbo and Hangzhou is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Hangzhou Prevail Optoelectroni in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hangzhou Prevail Opt and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Hangzhou Prevail. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hangzhou Prevail Opt has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Hangzhou Prevail go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Hangzhou Prevail

Assuming the 90 days trading horizon Ningbo MedicalSystem is expected to generate 1.3 times less return on investment than Hangzhou Prevail. But when comparing it to its historical volatility, Ningbo MedicalSystem Biotechnology is 1.29 times less risky than Hangzhou Prevail. It trades about 0.13 of its potential returns per unit of risk. Hangzhou Prevail Optoelectronic is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,565  in Hangzhou Prevail Optoelectronic on September 1, 2024 and sell it today you would earn a total of  497.00  from holding Hangzhou Prevail Optoelectronic or generate 31.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Ningbo MedicalSystem Biotechno  vs.  Hangzhou Prevail Optoelectroni

 Performance 
       Timeline  
Ningbo MedicalSystem 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.
Hangzhou Prevail Opt 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Hangzhou Prevail Optoelectronic are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hangzhou Prevail sustained solid returns over the last few months and may actually be approaching a breakup point.

Ningbo MedicalSystem and Hangzhou Prevail Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningbo MedicalSystem and Hangzhou Prevail

The main advantage of trading using opposite Ningbo MedicalSystem and Hangzhou Prevail positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Hangzhou Prevail can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hangzhou Prevail will offset losses from the drop in Hangzhou Prevail's long position.
The idea behind Ningbo MedicalSystem Biotechnology and Hangzhou Prevail Optoelectronic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios